Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026)

Medpace Holdings has reported Non-Current Deferred Tax Liability for 12 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 113.55% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 113.55% YoY), and the FY2025 full-year result was $1.4 million, down 24.72% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $3.9 million, up from $1.4 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $47.1 million in Q4 2022, with the low at $911000.0 in Q3 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $4.4 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 4264.17% — and 2023, when it tumbled 94.9%.
• Medpace Holdings' Non-Current Deferred Tax Liability stood at $47.1 million in 2022, then plunged by 94.9% to $2.4 million in 2023, then retreated by 25.12% to $1.8 million in 2024, then dropped by 24.72% to $1.4 million in 2025, then surged by 189.67% to $3.9 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $3.9 million (Q1 2026), $1.4 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.